Fundraising FoxTamir Biotechnology
San Diego, US · Delaware corporation · 3 employees on LinkedIn · 1 known investors
Find your way into Tamir Biotechnology
Sign up to see every warm intro you have to Tamir Biotechnology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tamir Biotechnology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JS
Jamie SulleyExecutive
JB
Joanne BarsaExecutive
Board
FK
Fred KnollBoard director
DS
DS
David SidrandkyBoard director
PO
Patrick OstronickBoard director
JB
John BrancaccioBoard director
PW
Paul WeissBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.2M disclosed across 4 rounds · 2014–2018
▶$808.6KraisedJan 2018 · 3 investors · BiotechnologyRule 506(b)
▶$808.6KraisedJan 2018 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jamie SulleyExecutive Officer, Director
- John BrancaccioDirector
- Patrick OstronicDirector
- Paul WeissDirector
- Joanne BarsaExecutive Officer
- Fred KnollDirector
- David SidranskyDirector
- Offering amount
- $1.5M
- Amount sold
- $808.6K
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedDec 2016 · 9 investors · BiotechnologyRule 506(b)
▶$1.7MraisedDec 2016 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joanne BarsaExecutive Officer
- John BrancaccioDirector
- Fred KnollDirector
- Patrick OstronickDirector
- David SidranskyDirector
- Jamie SulleyExecutive Officer, Director
- Paul WeissDirector
- Offering amount
- $1.7M
- Amount sold
- $1.7M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$800KraisedSep 2015 · 7 investors · BiotechnologyRule 506(b)
▶$800KraisedSep 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Fred KnollDirector
- David SidranskyDirector
- Patrick OstronickDirector
- John BrancaccioDirector
- Jamie SulleyExecutive Officer, Director
- Paul WeissDirector
- Joanne BarsaExecutive Officer
- Offering amount
- $800K
- Amount sold
- $800K
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$850.3KraisedMay 2014 · 9 investors · BiotechnologyRule 506(b)
▶$850.3KraisedMay 2014 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joanne BarsaExecutive Officer
- Fred KnollDirector
- David SidrandkyDirector
- Jamie SulleyExecutive Officer, Director
- John BrancaccioDirector
- Paul WeissDirector
- Patrick OstronickDirector
- Amount sold
- $850.3K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Tamir Biotechnology's investors?
- Tamir Biotechnology's investors include Israel Biotech Fund.
- How much funding has Tamir Biotechnology raised?
- Tamir Biotechnology has disclosed $4.2M raised across 4 rounds.
- Where is Tamir Biotechnology headquartered?
- Tamir Biotechnology is headquartered in San Diego, US.